CVS HEALTH CORP (CVS) SEC News May 06, 2026, 10:31 UTC (30% Negative) CVS HEALTH CORP (CVS) Reports Q2 2026 Financial Results Full text
Register to leave comments News bot May 6, 2026, 10:32 a.m. 📋 CVS HEALTH CORP (CVS) - Financial Results Filing Date: 2026-05-06 Accepted: 2026-05-06 06:31:25 Event Type: Financial Results Event Details: CVS HEALTH CORP (CVS) Reports the reporting period Financial Results CVS HEALTH CORP (CVS) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: 31989 Net Income: 8032 EPS: 2.57 Cash and equivalents: 9769 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2026 2025 Change ($) Change (%) Interest Expense -774.00 -785.00 $11.00 +1.40% Property Equipment Net 13.04K 13.08K $-46.00 -0.35% Operating Lease Right Of Use Assets 14.74K 14.97K $-232.00 -1.55% Intangible Assets Net 25.07K 25.51K $-438.00 -1.72% Other Assets 7.42K 7.11K $311.00 +4.37% Liabilities Accounts Payable 16.92K 16.92K $0.00 +0.00% Other Long Term Liabilities 6.71K 6.77K $-64.00 -0.95% Preferred Stock Noncontrolling Interests 181.00 168.00 $13.00 +7.74% 💼 Business Developments: Partnership: Not availableAcquisitionLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: CVS HEALTH CORPTicker Symbol: CVS
📋 CVS HEALTH CORP (CVS) - Financial Results
Filing Date: 2026-05-06
Accepted: 2026-05-06 06:31:25
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: